CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $47,000 | +161.1% | 2,580 | +164.3% | 0.00% | – |
| Q3 2020 | $18,000 | -41.9% | 976 | -53.5% | 0.00% | – |
| Q2 2020 | $31,000 | -61.2% | 2,101 | -58.7% | 0.00% | – |
| Q1 2020 | $80,000 | +105.1% | 5,083 | +109.5% | 0.00% | – |
| Q4 2019 | $39,000 | +62.5% | 2,426 | +50.5% | 0.00% | – |
| Q3 2019 | $24,000 | -56.4% | 1,612 | -51.3% | 0.00% | – |
| Q2 2019 | $55,000 | +3.8% | 3,310 | +7.7% | 0.00% | – |
| Q1 2019 | $53,000 | +3.9% | 3,074 | +6.0% | 0.00% | – |
| Q4 2018 | $51,000 | -12.1% | 2,900 | -8.9% | 0.00% | – |
| Q3 2018 | $58,000 | +61.1% | 3,185 | +73.1% | 0.00% | – |
| Q2 2018 | $36,000 | – | 1,840 | +4617.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 39 | -99.7% | 0.00% | – |
| Q4 2016 | $160,000 | +1042.9% | 12,245 | +1131.9% | 0.00% | – |
| Q3 2016 | $14,000 | -6.7% | 994 | -18.5% | 0.00% | – |
| Q2 2016 | $15,000 | -90.1% | 1,220 | -84.9% | 0.00% | – |
| Q1 2016 | $151,000 | +135.9% | 8,086 | +171.5% | 0.00% | – |
| Q4 2015 | $64,000 | – | 2,978 | +148800.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 2 | -98.4% | 0.00% | – |
| Q2 2015 | $5,000 | – | 128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|